S&P 500   3,819.72
DOW   31,270.09
QQQ   309.16
S&P 500   3,819.72
DOW   31,270.09
QQQ   309.16
S&P 500   3,819.72
DOW   31,270.09
QQQ   309.16
S&P 500   3,819.72
DOW   31,270.09
QQQ   309.16
Log in

RBC Life Sciences Stock Forecast, Price & News

0.00 (0.00 %)
(As of 03/3/2021 12:00 AM ET)
Today's Range
Now: $0.11
50-Day Range
MA: $0.13
52-Week Range
Now: $0.11
Average Volume1,175 shs
Market Capitalization$243,100.00
P/E RatioN/A
Dividend YieldN/A
RBC Life Sciences, Inc. manufactures, markets, and distributes nutritional supplements and personal care products in North America, Southeast Asia, and Australia. The company's Nutritional Products segment offers nutritional supplements and personal care products, including herbs, vitamins, and minerals; and natural skin, hair, and body care products through a network of independent distributors and license arrangements. Its products include Stem-Kine, a dietary supplement; Microhydrin and Microhydrin Plus antioxidants; VitAloe, a blend of research-backed ingredients; OliViva, an antioxidant beverage to support immune and cardiovascular system; Organic Spirulina, a nutritious alga that provides range of nutrients and easily digested proteins; and NeuroBright to support brain function, and enhance energy and acuity. This segments products also comprise Colo-Vada Plus, a colon cleansing program; HydraCel to enhance the quality of drinking water; 24 Seven, a multivitamin/mineral supplement; Immune 360 to nourish and support the function of the immune system; and Aloe Gelee gel that provides the soothing and moisturizing. Its Medical Products segment offers wound care products for the treatment and healing of wounds, such as pressure ulcers, leg ulcers, cuts, burns, and abrasions. Its products include cleansers, dressings, hydrogels, collagen, calcium alginates, moisture barriers, antimicrobials, and a hydrogel wound dressing with Lidocaine. This segment also offers other wound care products designed to reduce destruction to skin and tissue caused by radiation; and to reduce pain and itching in the skin, and the internal mucosa caused by radiation reactions or reactions to various cancer medications. This segment sells its products under the MPM Medical brand to hospitals, nursing homes, clinics, and pharmacies through a network of medical/surgical supply dealers and pharmaceutical distributors. The company was founded in 1988 and is headquartered in Irving, Texas.


Table of Experts: Future of Cities
February 5, 2021 |  bizjournals.com
Walmart best positioned for 2021 says RBC
December 22, 2020 |  cnbc.com
UK to expedite drug trials post-Brexit - FT
December 20, 2020 |  msn.com
See More Headlines

Industry, Sector and Symbol

Industry Miscellaneous nondurable goods
Current SymbolOTCMKTS:RBCL
Year FoundedN/A



Sales & Book Value

Annual SalesN/A



Market Cap$243,100.00
Next Earnings DateN/A
OptionableNot Optionable


Overall MarketRank

0.63 out of 5 stars

Medical Sector

1310th out of 1,968 stocks

Miscellaneous Nondurable Goods Industry

5th out of 6 stocks

Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 0.0 5 -4 -3 -2 -1 -
0.00 (0.00 %)
(As of 03/3/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive RBCL News and Ratings via Email

Sign-up to receive the latest news and ratings for RBCL and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

RBC Life Sciences (OTCMKTS:RBCL) Frequently Asked Questions

What stocks does MarketBeat like better than RBC Life Sciences?

Wall Street analysts have given RBC Life Sciences a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but RBC Life Sciences wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How has RBC Life Sciences' stock been impacted by Coronavirus?

RBC Life Sciences' stock was trading at $0.49 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, RBCL stock has decreased by 77.6% and is now trading at $0.11.
View which stocks have been most impacted by COVID-19

Who are RBC Life Sciences' key executives?

RBC Life Sciences' management team includes the following people:
  • Mr. Clinton H. Howard, Founder & Chairman (Age 93, Pay $313.18k)
  • Mr. Steven E. Brown, COO & Director (Age 66)
  • Mr. David Price, Acting Chief Exec. Officer

Who are some of RBC Life Sciences' key competitors?

What other stocks do shareholders of RBC Life Sciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other RBC Life Sciences investors own include NVIDIA (NVDA), Arcadis (ARCVF), AdvancePierre Foods Holdings, I (APFH), Artisan Partners Asset Management (APAM), American Superconductor (AMSC), ARCAM/SH (AMAVF), Allison Transmission (ALSN), Alico (ALCO), Apollo Investment (AINV) and 109051 (ACAT).

What is RBC Life Sciences' stock symbol?

RBC Life Sciences trades on the OTCMKTS under the ticker symbol "RBCL."

How do I buy shares of RBC Life Sciences?

Shares of RBCL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is RBC Life Sciences' stock price today?

One share of RBCL stock can currently be purchased for approximately $0.11.

How much money does RBC Life Sciences make?

RBC Life Sciences has a market capitalization of $243,100.00.

How many employees does RBC Life Sciences have?

RBC Life Sciences employs 89 workers across the globe.

What is RBC Life Sciences' official website?

The official website for RBC Life Sciences is www.rbclifesciences.com.

Where are RBC Life Sciences' headquarters?

RBC Life Sciences is headquartered at 2301 CROWN COURT, IRVING TX, 75038.

How can I contact RBC Life Sciences?

RBC Life Sciences' mailing address is 2301 CROWN COURT, IRVING TX, 75038. The company can be reached via phone at 972-893-4000 or via email at [email protected]

This page was last updated on 3/4/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.